An increased production of anti-inflammatory IL-10 and IL-17 by M2-like macrophages has been found to induce the expression of ECM degradation enzymes and angiogenic markers, thus supporting tumor angiogenesis and migration [41]. The gene discussed is IL17A; the disease is neoplasm.